Kjell Rosén

Recent publications · Crossref

5 total works indexed

1. Applied Predictive Modeling

   · 2013 · cited 4,222x

2. Phase 3 Trial of ¹⁷⁷ Lu-Dotatate for Midgut Neuroendocrine Tumors

   · 2017 · cited 2,872x

3. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

   · 2019 · cited 2,538x

4. Everolimus for Advanced Pancreatic Neuroendocrine Tumors

   · 2011 · cited 2,406x

5. The gut microbiota influences blood-brain barrier permeability in mice

   · 2014 · cited 2,201x

via Crossref · CC0

Wikidata facts

Image

Kjell Rosén.jpg